CSF kappa light chains and gadolinium-enhancing brain lesions as predictors of response to therapy with interferon beta 1a (Avonex®) in patients with relapsing multiple sclerosis
Publication
, Conference
Rudick, R; Cookfair, D; Simon, J; Simonian, N; Jacobs, L; Herndon, R; Richert, J; Salazar, A; Fischer, J; Granger, C; Goodkin, D; O'Reilly, K ...
Published in: NEUROLOGY
1998
Duke Scholars
Published In
NEUROLOGY
ISSN
0028-3878
Publication Date
1998
Volume
50
Issue
4
Start / End Page
A342 / A342
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rudick, R., Cookfair, D., Simon, J., Simonian, N., Jacobs, L., Herndon, R., … Boyle, S. (1998). CSF kappa light chains and gadolinium-enhancing brain lesions as predictors of response to therapy with interferon beta 1a (Avonex®) in patients with relapsing multiple sclerosis. In NEUROLOGY (Vol. 50, pp. A342–A342).
Rudick, R., D. Cookfair, J. Simon, N. Simonian, L. Jacobs, R. Herndon, J. Richert, et al. “CSF kappa light chains and gadolinium-enhancing brain lesions as predictors of response to therapy with interferon beta 1a (Avonex®) in patients with relapsing multiple sclerosis.” In NEUROLOGY, 50:A342–A342, 1998.
Rudick R, Cookfair D, Simon J, Simonian N, Jacobs L, Herndon R, et al. CSF kappa light chains and gadolinium-enhancing brain lesions as predictors of response to therapy with interferon beta 1a (Avonex®) in patients with relapsing multiple sclerosis. In: NEUROLOGY. 1998. p. A342–A342.
Rudick, R., et al. “CSF kappa light chains and gadolinium-enhancing brain lesions as predictors of response to therapy with interferon beta 1a (Avonex®) in patients with relapsing multiple sclerosis.” NEUROLOGY, vol. 50, no. 4, 1998, pp. A342–A342.
Rudick R, Cookfair D, Simon J, Simonian N, Jacobs L, Herndon R, Richert J, Salazar A, Fischer J, Granger C, Goodkin D, O’Reilly K, Boyle S. CSF kappa light chains and gadolinium-enhancing brain lesions as predictors of response to therapy with interferon beta 1a (Avonex®) in patients with relapsing multiple sclerosis. NEUROLOGY. 1998. p. A342–A342.
Published In
NEUROLOGY
ISSN
0028-3878
Publication Date
1998
Volume
50
Issue
4
Start / End Page
A342 / A342
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences